Loading…
Candida glabrata Endophthalmitis Treated Successfully with Caspofungin
A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antif...
Saved in:
Published in: | Clinical infectious diseases 2005-03, Vol.40 (5), p.e46-e48 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3 |
container_end_page | e48 |
container_issue | 5 |
container_start_page | e46 |
container_title | Clinical infectious diseases |
container_volume | 40 |
creator | Sarria, Juan C. Bradley, Jay C. Habash, Ranya Mitchell, Kelly T. Kimbrough, Robert C. Vidal, Ana M. |
description | A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed. |
doi_str_mv | 10.1086/427753 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67441469</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1086/427753</oup_id><sourcerecordid>67441469</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3</originalsourceid><addsrcrecordid>eNqF0EtLxDAUBeAgim9_glQX7qq5zXspxfGBIvgAcRPSJnGqnbYmLeq_tzKDgiCu7l18HDgHoR3Ah4AlP6KZEIwsoXVgRKScKVgef8xkSiWRa2gjxmeMASRmq2gNmABKsVhHk9w0trImeapNEUxvkpPGtt20n5p6VvVVTO6CM72zye1Qli5GP9T1R_JW9dMkN7Fr_dA8Vc0WWvGmjm57cTfR_eTkLj9LL69Pz_Pjy7SkBPqUYmoNWFFiQjlRLvMlSPC4YIIpb6zLlCmVZ54Sj3nGJQDhCoO0BeVFZsgmOpjndqF9HVzs9ayKpatr07h2iJoLSoFy9S8EIbFQWTbC_V_wuR1CM5bQGShFvxb7SStDG2NwXnehmpnwoQHrr_31fP8R7i7ShmLm7A9bDD6CvTloh-7vkHRuqti7929lwsvYjwimzx4e9QTf8lzeXOgr8glLNJb9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219941805</pqid></control><display><type>article</type><title>Candida glabrata Endophthalmitis Treated Successfully with Caspofungin</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford Journals Online</source><creator>Sarria, Juan C. ; Bradley, Jay C. ; Habash, Ranya ; Mitchell, Kelly T. ; Kimbrough, Robert C. ; Vidal, Ana M.</creator><creatorcontrib>Sarria, Juan C. ; Bradley, Jay C. ; Habash, Ranya ; Mitchell, Kelly T. ; Kimbrough, Robert C. ; Vidal, Ana M.</creatorcontrib><description>A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/427753</identifier><identifier>PMID: 15714407</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Adult ; Antifungal Agents - therapeutic use ; Candida glabrata ; Candida glabrata - drug effects ; Candida glabrata - isolation & purification ; Candidiasis - diagnosis ; Candidiasis - drug therapy ; Candidiasis - microbiology ; Drug Resistance, Multiple, Fungal ; Echinocandins ; Endophthalmitis - drug therapy ; Endophthalmitis - microbiology ; Endophthalmitis - pathology ; Humans ; Lipopeptides ; Male ; Peptides, Cyclic - therapeutic use</subject><ispartof>Clinical infectious diseases, 2005-03, Vol.40 (5), p.e46-e48</ispartof><rights>2005 by the Infectious Diseases Society of America 2005</rights><rights>Copyright National Library of Medicine - MEDLINE Abstracts Mar 1 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3</citedby><cites>FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15714407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sarria, Juan C.</creatorcontrib><creatorcontrib>Bradley, Jay C.</creatorcontrib><creatorcontrib>Habash, Ranya</creatorcontrib><creatorcontrib>Mitchell, Kelly T.</creatorcontrib><creatorcontrib>Kimbrough, Robert C.</creatorcontrib><creatorcontrib>Vidal, Ana M.</creatorcontrib><title>Candida glabrata Endophthalmitis Treated Successfully with Caspofungin</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.</description><subject>Adult</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Candida glabrata</subject><subject>Candida glabrata - drug effects</subject><subject>Candida glabrata - isolation & purification</subject><subject>Candidiasis - diagnosis</subject><subject>Candidiasis - drug therapy</subject><subject>Candidiasis - microbiology</subject><subject>Drug Resistance, Multiple, Fungal</subject><subject>Echinocandins</subject><subject>Endophthalmitis - drug therapy</subject><subject>Endophthalmitis - microbiology</subject><subject>Endophthalmitis - pathology</subject><subject>Humans</subject><subject>Lipopeptides</subject><subject>Male</subject><subject>Peptides, Cyclic - therapeutic use</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqF0EtLxDAUBeAgim9_glQX7qq5zXspxfGBIvgAcRPSJnGqnbYmLeq_tzKDgiCu7l18HDgHoR3Ah4AlP6KZEIwsoXVgRKScKVgef8xkSiWRa2gjxmeMASRmq2gNmABKsVhHk9w0trImeapNEUxvkpPGtt20n5p6VvVVTO6CM72zye1Qli5GP9T1R_JW9dMkN7Fr_dA8Vc0WWvGmjm57cTfR_eTkLj9LL69Pz_Pjy7SkBPqUYmoNWFFiQjlRLvMlSPC4YIIpb6zLlCmVZ54Sj3nGJQDhCoO0BeVFZsgmOpjndqF9HVzs9ayKpatr07h2iJoLSoFy9S8EIbFQWTbC_V_wuR1CM5bQGShFvxb7SStDG2NwXnehmpnwoQHrr_31fP8R7i7ShmLm7A9bDD6CvTloh-7vkHRuqti7929lwsvYjwimzx4e9QTf8lzeXOgr8glLNJb9</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Sarria, Juan C.</creator><creator>Bradley, Jay C.</creator><creator>Habash, Ranya</creator><creator>Mitchell, Kelly T.</creator><creator>Kimbrough, Robert C.</creator><creator>Vidal, Ana M.</creator><general>The University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Candida glabrata Endophthalmitis Treated Successfully with Caspofungin</title><author>Sarria, Juan C. ; Bradley, Jay C. ; Habash, Ranya ; Mitchell, Kelly T. ; Kimbrough, Robert C. ; Vidal, Ana M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Candida glabrata</topic><topic>Candida glabrata - drug effects</topic><topic>Candida glabrata - isolation & purification</topic><topic>Candidiasis - diagnosis</topic><topic>Candidiasis - drug therapy</topic><topic>Candidiasis - microbiology</topic><topic>Drug Resistance, Multiple, Fungal</topic><topic>Echinocandins</topic><topic>Endophthalmitis - drug therapy</topic><topic>Endophthalmitis - microbiology</topic><topic>Endophthalmitis - pathology</topic><topic>Humans</topic><topic>Lipopeptides</topic><topic>Male</topic><topic>Peptides, Cyclic - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarria, Juan C.</creatorcontrib><creatorcontrib>Bradley, Jay C.</creatorcontrib><creatorcontrib>Habash, Ranya</creatorcontrib><creatorcontrib>Mitchell, Kelly T.</creatorcontrib><creatorcontrib>Kimbrough, Robert C.</creatorcontrib><creatorcontrib>Vidal, Ana M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarria, Juan C.</au><au>Bradley, Jay C.</au><au>Habash, Ranya</au><au>Mitchell, Kelly T.</au><au>Kimbrough, Robert C.</au><au>Vidal, Ana M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Candida glabrata Endophthalmitis Treated Successfully with Caspofungin</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>40</volume><issue>5</issue><spage>e46</spage><epage>e48</epage><pages>e46-e48</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>15714407</pmid><doi>10.1086/427753</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-4838 |
ispartof | Clinical infectious diseases, 2005-03, Vol.40 (5), p.e46-e48 |
issn | 1058-4838 1537-6591 |
language | eng |
recordid | cdi_proquest_miscellaneous_67441469 |
source | JSTOR Archival Journals and Primary Sources Collection; Oxford Journals Online |
subjects | Adult Antifungal Agents - therapeutic use Candida glabrata Candida glabrata - drug effects Candida glabrata - isolation & purification Candidiasis - diagnosis Candidiasis - drug therapy Candidiasis - microbiology Drug Resistance, Multiple, Fungal Echinocandins Endophthalmitis - drug therapy Endophthalmitis - microbiology Endophthalmitis - pathology Humans Lipopeptides Male Peptides, Cyclic - therapeutic use |
title | Candida glabrata Endophthalmitis Treated Successfully with Caspofungin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A48%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Candida%20glabrata%20Endophthalmitis%20Treated%20Successfully%20with%20Caspofungin&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Sarria,%20Juan%20C.&rft.date=2005-03-01&rft.volume=40&rft.issue=5&rft.spage=e46&rft.epage=e48&rft.pages=e46-e48&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/427753&rft_dat=%3Cproquest_cross%3E67441469%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-404da1d7c034639e2fc181f0b5759fade29ac9f5f43f0626811369018db46b2a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=219941805&rft_id=info:pmid/15714407&rft_oup_id=10.1086/427753&rfr_iscdi=true |